Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Viewpoints
Showing 2817 - 2824 of 12086 results

Mintz Adds ITC Pro From Adduci Mastriani
November 3, 2021| News

What’s New in 5G - November 2021
November 3, 2021| Blog| Viewpoint

NYSDOL Issues Guidance Regarding Employee Use of Cannabis
November 3, 2021| Blog| Viewpoint

Importance of a Firm Brand: Passle Podcast CMO Series
November 3, 2021| Podcast| Viewpoint

Mintz Life Sciences Deal Activity (July– September 2021)
November 1, 2021| Article| Viewpoint

Briefings on HIPAA: Inside the 21st Century ONC Cures Act
November 1, 2021| News

Life Sciences CEO Interview: Joe Payne, President and CEO of Arcturus Therapeutics
November 1, 2021| Blog| Viewpoint

Roller Derby Team Ups Heat in Cleveland Guardians Trademark Fight
October 29, 2021| News
News & Press Releases
Mintz advised the creators of Morbid, one of the top-charting true crime podcasts, in a multi-year agreement to move to SiriusXM from Wondery. The deal gives SiriusXM exclusive advertising rights for the audio and video formats of the podcast.
Mintz Advises CVC DIF in Acquisition of SBA Communications’ Canadian Tower Infrastructure Platform
August 06, 2025
Mintz advised CVC DIF, the dedicated infrastructure investment strategy of global private markets manager CVC, in its agreement to acquire SBA Communications’ Canadian wireless tower business, one of Canada’s leading independent owners and operators of wireless communications towers. The transaction is expected to close in the fourth quarter of 2025, subject to customary closing conditions.
Mintz advised the underwriters in connection with a $69 million public offering by Larimar Therapeutics, Inc. of 21,562,500 shares of its common stock at a price to the public of $3.20 per share. The gross proceeds to Larimar from the offering were $69 million before deducting underwriting discounts and commissions and other offering expenses.
Events
Podcasts

Mintz On Air: Practical Policies — A Private Equity Non-Compete Primer
July 15, 2025| Podcast|

Health Law Diagnosed – Best Practices for Communicating with the FDA
July 9, 2025| Podcast|
